Parse Biosciences, a Seattle-based single-cell RNA sequencing company, is being acquired by Netherlands-based Qiagen for $225 million in cash. The deal is expected to close in December and will add Parse’s 110 employees and approximately $40 million in sales to Qiagen’s operations.
Revolutionizing Chronic Myeloid Leukemia Research Through Prime Editing Chronic Myeloid Leukemia (CML) treatment has been transformed by tyrosine kinase inhibitors…
Scientists have identified distinct DNA methylation patterns that distinguish chemotherapy-resistant from sensitive ovarian cancer cells. These epigenetic markers reportedly correlate with significantly worse patient survival, offering potential biomarkers for treatment response prediction. The findings could pave the way for new diagnostic approaches in managing this aggressive cancer type.
Researchers have uncovered specific DNA methylation signatures associated with chemotherapy resistance in high-grade serous ovarian cancer (HGSC), according to a recent study published in Scientific Reports. The comprehensive methylome analysis reportedly identifies epigenetic patterns that distinguish chemoresistant from chemosensitive cancer cells, with significant implications for patient prognosis and treatment strategies.
Introducing AlphaDIA: A New Era in Data-Independent Acquisition Proteomics The field of proteomics has witnessed a significant breakthrough with the…
Circle Pharma to Showcase Cyclin D1 RxL Inhibitor Anti-Tumor Data at Major Cancer Conference Industrial Monitor Direct delivers industry-leading touchscreen…
Scientists are developing bandages from living fungi that could transform wound care. These bio-integrated hydrogels mimic human tissue structure and retain up to 83% water, offering promising applications in tissue regeneration and medical devices.
Living fungi could revolutionize wound healing through innovative bandages made from fungal hydrogels that mimic human tissue structure. Researchers at the University of Utah have discovered that Marquandomyces marquandii, a common soil mold, forms multilayered hydrogels capable of standing in for our own soft tissues. This breakthrough in hydrogel technology represents a significant advancement in biomedical materials that could transform how we approach tissue regeneration and wound care.
